Bitcoin halving
What does that mean?
$2.45T
Total marketcap
$74.79B
Total volume
BTC 51.43%     ETH 15.03%
Dominance

ResMed Inc. RSMDF Stock

19.06 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
Other OTC
Market Cap
28.04B USD
LOW - HIGH [24H]
19.06 - 19.06 USD
VOLUME [24H]
40K USD
{{ volume }}
P/E Ratio
31.76
Earnings per share
0.6 USD

ResMed Inc. Price Chart

ResMed Inc. RSMDF Financial and Trading Overview

ResMed Inc. stock price 19.06 USD
Previous Close 21.7 USD
Open 21.7 USD
Bid N/A x N/A
Ask N/A x N/A
Day's Range 21.7 - 21.7 USD
52 Week Range 1.9 - 24.18 USD
Volume 1.05K USD
Avg. Volume 25 USD
Market Cap 31.88B USD
Beta (5Y Monthly) 0.480633
PE Ratio (TTM) 36.779663
EPS (TTM) 0.6 USD
Forward Dividend & Yield 0.18 (0.80%)
Ex-Dividend Date May 10, 2023
1y Target Est 11.49 USD

RSMDF Valuation Measures

Enterprise Value 14.24B USD
Trailing P/E 36.779663
Forward P/E 52.92683
PEG Ratio (5 yr expected) 2.72
Price/Sales (ttm) 7.939896
Price/Book (mrq) 3.2429202
Enterprise Value/Revenue 3.546
Enterprise Value/EBITDA 11.358

Trading Information

ResMed Inc. Stock Price History

Beta (5Y Monthly) 0.480633
52-Week Change -1.36%
S&P500 52-Week Change 20.43%
52 Week High 24.18 USD
52 Week Low 1.9 USD
50-Day Moving Average 21.7 USD
200-Day Moving Average 21.84 USD

RSMDF Share Statistics

Avg. Volume (3 month) 25 USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 1.47B
Float 582.27M
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 7.55%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 1.74
Trailing Annual Dividend Yield 8.01%
5 Year Average Dividend Yield N/A
Payout Ratio 0.2969
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End June 30, 2023

Profitability

Profit Margin 21.49%
Operating Margin (ttm) 27.92%
Gross Margin 57.00%
EBITDA Margin 31.21%

Management Effectiveness

Return on Assets (ttm) 12.06%
Return on Equity (ttm) 23.93%

Income Statement

Revenue (ttm) 4.02B USD
Revenue Per Share (ttm) 6.85 USD
Quarterly Revenue Growth (yoy) 29.19%
Gross Profit (ttm) 2.06B USD
EBITDA 1.25B USD
Net Income Avi to Common (ttm) 862.95M USD
Diluted EPS (ttm) 0.59
Quarterly Earnings Growth (yoy) 29.89%

Balance Sheet

Total Cash (mrq) 240.01M USD
Total Cash Per Share (mrq) 0.41 USD
Total Debt (mrq) 1.72B USD
Total Debt/Equity (mrq) 43.84 USD
Current Ratio (mrq) 3.069
Book Value Per Share (mrq) 6.6915

Cash Flow Statement

Operating Cash Flow (ttm) 535.35M USD
Levered Free Cash Flow (ttm) 288.28M USD

Profile of ResMed Inc.

Country United States
State CA
City San Diego
Address 9001 Spectrum Center Boulevard
ZIP 92123
Phone 858 836 5000
Website https://www.resmed.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 8160

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Q&A For ResMed Inc. Stock

What is a current RSMDF stock price?

ResMed Inc. RSMDF stock price today per share is 19.06 USD.

How to purchase ResMed Inc. stock?

You can buy RSMDF shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for ResMed Inc.?

The stock symbol or ticker of ResMed Inc. is RSMDF.

Which industry does the ResMed Inc. company belong to?

The ResMed Inc. industry is Medical Instruments & Supplies.

How many shares does ResMed Inc. have in circulation?

The max supply of ResMed Inc. shares is 1.47B.

What is ResMed Inc. Price to Earnings Ratio (PE Ratio)?

ResMed Inc. PE Ratio is 31.76666500 now.

What was ResMed Inc. earnings per share over the trailing 12 months (TTM)?

ResMed Inc. EPS is 0.6 USD over the trailing 12 months.

Which sector does the ResMed Inc. company belong to?

The ResMed Inc. sector is Healthcare.